How can we help you? – 25th EHA Congress-Virtual

Request a quote today

Our portfolio of Oncomine hemato-oncology research assays is growing. Whether you're interested in the assessment of myeloid or lymphoid malignancy samples, we provide the comprehensive suite of tools you need to simplify and accelerate your path to answers.

(*Indicates a mandatory field)

What is your area of interest? (select 3 max)*	Request sales rep contact with pricing
Ion Torrent Genexus System This system offers specimen to report in a single day with a hands-off, automated workflow.
Oncomine Myeloid NGS solutions Simplify and accelerate myeloid profiling with NGS for RNA and DNA.
Oncomine Lymphoid NGS solutions With customisable content, the Oncomine Lymphoma panel contains 25 key genes associated with all major B-cell lymphomas.
Oncomine BCR/TCR NGS sequencing Oncomine BCR/TCR assays are sensitive NGS assays that make it easier to assess the BCR/TCR repertoire and detect rare clones in hemato-oncology research.
CytoScan and OncoScan products for Leukemia/lymphoma High-performance cytogenetics microarray solutions for chromosomal aberrations and Copy Number Variations (CNV) analysis in cancer, from whole genome coverage to single exon focus.
Applied Biosystems Genetic Analyzers Applied Biosystems genetic analyzers are a trusted standard for Sanger sequencing and fragment analysis by capillary electrophoresis (CE).
Applied Biosystems QuantStudio Real-time PCR Systems As a leader in PCR innovation, we offer you the gold standard in real-time PCR instrumentation with excellent performance, reliability, and world-class support.

First name*

Last name*

Telephone*

Email*

Institution*

City*

Postal Code/Zip*

Country/Region*

Please selectAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaireBosnia & HerzegovinaBotswanaBouvet IslandBrasilBritish Indian OceanBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCook IslandsCosta RicaCôte D'IvoireCroatiaCuracaoCyprusCzech RepublicDemocratic Republic of CongoDenmarkDjiboutiDominicaDominican RepublicTIMOR-LESTEEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFederated States of MicronesiaFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuianaGuineaGuinea - BissauHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIraqIrelandIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSan MarinoSão Tomé and PríncipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSaint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSamoaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUnited KingdomUkraineUnited Arab EmiratesUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin IslandsWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Submit